Moderna’s ‘Off-the-Shelf’ Cancer Vaccine Shows Promise in Early Human Trial Data
The therapeutic vaccine, codenamed mRNA-4359, is intended to boost people's immunity to a variety of advanced solid tumor ...
Moderna Stock Jumps on Canadian Government's Approval of Updated COVID-19 Vaccine
The company reported Health Canada authorized the use of its Spikevax KP.2 shot for those aged six months and older. Last ...
Moderna's updated COVID-19 vaccine for 2024-25 approved in Canada
Health Canada authorized Moderna's updated COVID-19 vaccine on Tuesday to roll out in fall and winter immunization campaigns.
What's Going On With Moderna Shares Tuesday?
Moderna shares are moving higher on Tuesday after the company announced that Health Canada approved its updated COVID-19 ...
Moderna Receives Health Canada Approval For Updated COVID-19 Vaccine Targeting KP.2 Variant Of SARS-COV-2 For Ages Six Months And Older
SPIKEVAX® is the first updated COVID-19 vaccine authorized in Canada for 2024-2025, offering a timely solution to help protect Canadians ...
What to know about the vaccines available this respiratory virus season
Covid-19 levels in the United States are high and rising, flu season is approaching quickly and RSV cases are already ...
FDA OKs third dose for Pfizer and Moderna Covid-19 vaccines
These extra doses will bring more highly specialised work making these novel molecules to contract manufacturing ...
The Gazette on MSN5d
Health Canada approves updated Moderna COVID-19 vaccine
TORONTO — Health Canada has authorized Moderna’s updated COVID-19 vaccine that protects against currently circulating ...
Latest COVID variant, XEC, has spread to half of US states, reports say
The latest strain of the COVID-19 virus, XEC, is circulating across the country. The new variant has been reported in at ...
Investopedia4d
Moderna Stock Jumps on Canadian Government's Approval of Updated COVID-19 Vaccine
These include white papers, government data, original reporting ... Moderna. "Moderna Receives Health Canada Approval For Updated COVID-19 Vaccine Targeting KP.2 Variant Of SARS-COV-2 For Ages ...